Evidence map›Paper›PMID 30201816›Full record

ArticleAntimicrobial agents and chemotherapy2018

Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens.

Ana Gomes, Ricardo Ferraz, Lauren Ficker, Margaret S Collins, Cristina Prudêncio, Melanie T Cushion, Cátia Teixeira, Paula Gomes

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Looking beyond Typical Treatments for Atypical Mycobacteria.Antibiotics (Basel, Switzerland) · 2020
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ana GomesLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Ricardo FerrazLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Lauren FickerCincinnati Veterans Affairs Medical Center, Cincinnati Education and Research for Veterans Foundation, Cincinnati, Ohio, USA.
Margaret S CollinsCincinnati Veterans Affairs Medical Center, Cincinnati Education and Research for Veterans Foundation, Cincinnati, Ohio, USA.
Cristina PrudêncioCiências Químicas e das Biomoléculas, Escola Superior de Saúde, Politécnico do Porto, Porto, Portugal.
Melanie T CushionCincinnati Veterans Affairs Medical Center, Cincinnati Education and Research for Veterans Foundation, Cincinnati, Ohio, USA.ORCID 0000-0001-6621-2784
Cátia TeixeiraLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Paula GomesLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal pgomes@fc.up.pt.ORCID 0000-0002-6018-4724
Universidade do Porto · PTi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PT

Funding

New Approaches for Development of PcP TherapyR01AI050450 · NIAID · UNIVERSITY OF CINCINNATI · PI CUSHION, MELANIE T · 2002 to 2006
$1.7M
NIAID NIH HHS R01 AI050450
6 · The paper itself

Abstract

The impact of

Indexed as

A549 CellsAntimalarialsCell Line, TumorChloroquineHumansImmunocompromised HostPneumocystis cariniiPneumonia, PneumocystisAntimalarialsChloroquinechloroquinecinnamic acidsimmunosuppressedlung infectionmalariaPneumocystispneumoniaprimaquine

Identifiers

PMID30201816
PMCPMC6201078
OpenAlexW2891762265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.